Abstract
Although asbestos is carcinogenic to humans, the mechanism(s) by which it induces cancer is unknown. Using tumor cell lines generated previously by asbestos treatment of immortalized human bronchial epithelial (BEP2D) cells, we examined alterations in p16 and p21Cip1 genes together with their protein levels. Results were compared with untreated BEP2D cells, normal human bronchial epithelial cells (NHBE), as well as non-tumorigenic fusion cell lines generated by fusing tumor cells with BEP2D cells. No deletion in the p16 gene was found in any of the tumor cell lines examined. Although p16 protein was expressed at a similar level in tumor and BEP2D cells, there was a fourfold decrease in its expression among NHBE cells. In contrast, both the protein and mRNA expression levels of p21Cip1 were decreased by about threefold in tumor cell lines when compared with either BEP2D or NHBE cells, which had a similar expression level. Expression of p21Cip1 mRNA was restored to the control level in all the fusion cell lines examined. The results suggested that down regulation of p21Cip1 expression is linked to the tumorigenic conversion of BEP2D cells by asbestos.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, Hoppe-Seyler F . 1995 Oncogene 10: 927–936
Cheng JQ, Jhanwar SC, Klein WM, Testa JR . 1994 Cancer Res. 54: 5547–5551
DeMuth JP, Jackson CM, Weaver DA, Willey JC . 1998 Am. J. Respir. Cell Mol. Biol. 19: 18–24
Gabrielle IT, Ryuhei O, Jose GG, Claudio C, Dotto GP . 1999 Proc. Natl. Acad. Sci. USA 96: 9089–9094
Gerwin B . 1994 Am. J. Respir. Cell Mol. Biol. 11: 507–515
Hei TK, Piao CQ, He ZY, Vannais D, Waldren CA . 1992 Cancer Res. 52: 6305–6309
Hei TK, Wu LJ, Piao CQ . 1997 Environ. Hlth. Persp. 105: 1085–1088
Hei TK, Piao CQ, Willey JC, Hall EJ . 1994 Carcinogenesis 15: 431–437
Hei TK, Piao CQ, Wu LJ, Willey JC, Hall EJ . 1998 Adv. Space. Res. 22: 1699–1707
Kamb A, Gruis NA, Weaver FJ, Liu O, Skolnick MH . 1994 Science 264: 436–440
Kokunai T, Lzawa I, Tamaki N . 1998 Int. J. Cancer 75: 643–648
Lezon-Geyda K, Jaime CM, Godbold JH, Savransky EF, Hope A, Kheiri SA, Dzmura ZM, Uehara H, Johnson EM, Fasy TM . 1996 Mutat. Res. 361: 113–120
Li CY, Suardet L, Little JB . 1995 J. Biol. Chem. 270: 4971–4974
Lechner JF, Tokiwa T, LaVeck M, Benedict WF, Harrs CC . 1985 Proc. Natl. Acad. Sci. USA 82: 3884–3889
Livington GM, Rom WN, Morrs MV . 1980 J. Environ. Pathol. Toxicol. 4: 373–382
Mossman BT, Bignon J, Corn M, Seaton A, Gee JBL . 1990 Science 247: 294–306
Marchetti A, Doglioni C, Barbareschi M, Bevilacqua G . 1996 Oncogene 12: 1319–1324
Missero C, Di cunto F, Kiyokawa H, Koff A, Dotto GP . 1996 Genes Dev. 10: 3065–3075
Nobori T, Miura K, Wu DJ, Carson DA . 1994 Nature 368: 753–756
Nakao Y, Yang X, Yokoyama M, Pater A . 1997 Br. J. Cancer 75: 1410–1416
Nadal A, Jares P, Cazorla M . 1997 J. Pathol. 183: 156–163
Okamoto A, Demetrick DJ, Spillare EA, Harris CC . 1994 Proc. Natl. Acad. Sci. USA 91: 11045–11049
Park SH, Aust AE . 1998 Cancer Res. 58: 1144–1148
Qiu X, Forman HJ, Schonthal AH, Cadenas E . 1996 J. Biol. Chem. 271: 31915–31921
Stanton MF, Layard M, Tegeris A . 1977 J. Natl. Cancer Inst. 58: 587–604
Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richads W, Rollins BJ . 1995 Cancer Res. 55: 505–509
Serrano M . 1997 Exp. Cell Res. 237: 7–13
Takeshima Y, Yamasaki M, Nishisaka T, Kitaguchi S, Inai K . 1998 Carcinogenesis 19: 1755–1761
Washimi O, Nagatake M, Osada H, Ueda R, Takahashi T . 1995 Cancer Res. 55: 514–517
Xiong Y, Zhang H, Beach D . 1993 Genes Dev. 7: 1572–1583
Xiong Y, Hannon GJ, Zhang H, Casso D, Beach D . 1993 Nature 366: 701–704
Xiao S, Li D, Vijg J, Sugarbaker D, Corson J, Fletcher J . 1995 Oncogene 11: 511–515
Zhao YL, Piao CQ, Wu LJ, Suzuki M, Hei TK . 2000 Carcinogenesis 21: 2005–2010
Acknowledgements
This work was supported by NIH grants ES07890 and ES05786.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piao, C., Zhao, Y. & Hei, T. Analysis of p16 and p21Cip1 expression in tumorigenic human bronchial epithelial cells induced by asbestos. Oncogene 20, 7301–7306 (2001). https://doi.org/10.1038/sj.onc.1204908
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204908
Keywords
This article is cited by
-
Lung injury and expression of p53 and p16 in Wistar rats induced by respirable chrysotile fiber dust from four primary areas of China
Environmental Science and Pollution Research (2018)
-
Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology
Archives of Toxicology (2015)
-
Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells
Oncogene (2002)